New laboratory pharmaceuticals of Air Liquide in Mérida

The company air Liquide Medicinal a pharmaceutical laboratory of medicinal gases whose investment reaches 2,800,000 euros. The investment made in this laboratory has been allocated to the adaptation of the existing plant to the stringent requirements that marks the Royal Decree 1800 / 2003 for the manufacture of medicinal gases. The laboratory is using the latest technologies for the preparation of medicinal gases in liquid and gaseous phase, and the traceability of production as the Spanish Pharmacopoeia and the standards of good manufacturing. To make possible this project the company has carried out an extension of the nave in 500 m2 and installed new equipment for production and control, as well as sophisticated computer systems that guarantee the quality of these gases medication at all times. Technologically, this Center is among the most advanced in Europe, production serves hospitals and patients of Extremadura, Castile and León, Spain, and Madrid and soon will serve the needs of Portugal.

To adapt to the new Air Liquide Medicinal rules it has invested more than 11.5 million euros. This economic effort responds to the need for the group to adapt its means of production, logistics and organization to the demands of the Royal Decree 1800 / 2003. The company has pharmaceutical laboratories in other communities such as Valencia, Asturias and Canary Islands. The laboratories have qualified personnel in the areas of quality control, production, and logistics that are responsible for managing manufacturing, the corresponding analytical checks to medicinal gases as well as the planning of the distribution routes. To ensure the traceability of gases, it has developed and launched a complete computer system which guaranteed, from the point of production to the point of delivery to the client.

During the ceremony of inauguration, Nicolás Espinosa, Director General medical Gases and Air Liquide Medicinal hospital services said that "Air Liquide Medicinal has always supported that the medicinal gases pass to be considered as drugs, because like these"their properties and applications impact favourably on the improvement of patients. "Air Liquide Medicinal works for and to increase the quality of life of the patient, and the change of name it will offer them greater guarantees in terms of their proper handling and treatment". The Air Liquide group has always supported the qualification of medicinal gases such as medication, measure that guarantees the quality of the product at hospitals and clinics, safety in its use for patients and the therapeutic efficacy, essential for optimal administration. Medicinal gases are under the protection of the GMP (good manufacturing standards) and the European Pharmacopoeia.

At the same event was the signing of the framework agreement of collaboration between Air Liquide Medicinal and the Fundesalud Foundation under the Ministry of health and Consumer Affairs. It's a commitment to cooperation for the training and research of health professionals. The signing was conducted as Guillermo Fernández Vara, Minister of health and consumption, and Philippe Lecerf, Director General of Air Liquide Medicinal home care.